|
GB202102575D0
|
|
Fixed-dose pharmaceutical compositions
|
|
GB201910776D0
|
|
Inhaler system
|
|
GB201906078D0
|
|
Inhaler system
|
|
WO2019025869A1
|
|
Additively manufactured controlled release dosage forms
|
|
GB201718553D0
|
|
Preparation of a glatiramer acetate drug product
|
|
BR112015021780A2
|
|
reusable syringe injector
|
|
AU2010304755A1
|
|
Use of rasagiline for the treatment of Progressive Supranuclear Palsy
|
|
AU2008296908A1
|
|
Method of treating glaucoma using rasagiline
|
|
AU2006211510A1
|
|
Process for producing polypeptide mixtures using hydrogenolysis
|
|
AU2005269416A1
|
|
Pharmaceutical dosage forms including rasagiline
|
|
AU2005249794A1
|
|
Pharmaceutical composition containing irbesartan
|
